Bioactivity:

BRD-6929 is a selective, brain-penetrant HDAC1 and HDAC2 inhibitor (IC50: _1 and 8 nM). BRD-6929 (Cpd-60) shows high-affinity to HDAC1 and HDAC2 (Kis: 0.2 and 1.5 nM) [2]. BRD-6929 potentiates the efficacy of gnidimacrin (a PKC Agonist) against latent HIV

CAS nr:

849234-64-6

Purity:

98%

Molecular Weight:

351,42

SMILES:

O=C(NC1=CC(C2=CC=CS2)=CC=C1N)C3=CC=C(NC(C)=O)C=C3

Formula:

C19H17N3O2S

Pathway:

DNA Damage/DNA Repair,Chromatin/Epigenetic,Proteases/Proteasome,Microbiology/Virology

Target:

HDAC,HDAC,HIV Protease,HIV Protease